BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.3202
+0.0202 (6.73%)
At close: Jan 22, 2026, 4:00 PM EST
0.3333
+0.0131 (4.09%)
After-hours: Jan 22, 2026, 4:51 PM EST
BioAtla Market Cap
BioAtla has a market cap or net worth of $20.48 million as of January 22, 2026. Its market cap has decreased by -47.93% in one year.
Market Cap
20.48M
Enterprise Value
16.90M
1-Year Change
-47.93%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $20.48M, a decrease of -96.45%. That is a compound annual growth rate of -48.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 19.04M | -43.19% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lunai Bioworks | 20.25M |
| CASI Pharmaceuticals | 20.00M |
| Allarity Therapeutics | 19.71M |
| Liminatus Pharma | 19.67M |
| Traws Pharma | 19.34M |
| VYNE Therapeutics | 18.78M |
| Lexaria Bioscience | 18.42M |
| OSR Holdings | 18.34M |